These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8372499

  • 1. Humanized anti-carcinoembryonic antigen antibody: strategies to enhance human tumor cell killing.
    Kaulen H, Seemann G, Bosslet K, Schwaeble W, Dippold W.
    Year Immunol; 1993; 7():106-9. PubMed ID: 8372499
    [No Abstract] [Full Text] [Related]

  • 2. The construction of a mouse/human chimeric antibody against human breast cancer cells.
    Meulemans E, Vandevyver C, Volckaert G, Raus J.
    Year Immunol; 1993; 7():131-6. PubMed ID: 8372502
    [No Abstract] [Full Text] [Related]

  • 3. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R.
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract] [Full Text] [Related]

  • 4. Generation of humanized monoclonal antibodies by 'best fit' framework selection and recombinant polymerase chain reaction.
    Lewis AP, Crowe JS.
    Year Immunol; 1993; 7():110-8. PubMed ID: 8372500
    [No Abstract] [Full Text] [Related]

  • 5. Cloning and characterization of 1116NS19.9 heavy and light chain cDNAs and expression of antibody fragments in Escherichia coli.
    Tonge DW, Hennam JF, Greene AR, Lee ID, Edge MD.
    Year Immunol; 1993; 7():56-62. PubMed ID: 8372513
    [No Abstract] [Full Text] [Related]

  • 6. Recombinant chimeric monoclonal antibodies.
    Morrison SL, Schlom J.
    Important Adv Oncol; 1990; ():3-18. PubMed ID: 2182522
    [No Abstract] [Full Text] [Related]

  • 7. Antigen binding and biological activities of engineered mutant chimeric antibodies with human tumor specificities.
    Gillies SD, Wesolowski JS.
    Hum Antibodies Hybridomas; 1990; 1(1):47-54. PubMed ID: 2129419
    [Abstract] [Full Text] [Related]

  • 8. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
    Williams LE, Wu AM, Yazaki PJ, Liu A, Raubitschek AA, Shively JE, Wong JY.
    Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
    [Abstract] [Full Text] [Related]

  • 9. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H, Arakawa F, Imakiire T, Kuroki M, Kuroki M.
    Anticancer Res; 2003 Feb; 23(6a):4383-8. PubMed ID: 14666725
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C, Dorn-Beineke A, Nittka S, Stocking C, Neumaier M.
    Cancer Res; 2005 Mar 01; 65(5):1925-33. PubMed ID: 15753392
    [Abstract] [Full Text] [Related]

  • 11. Bacterial expression of a kemptide fusion protein facilitates 32P labeling of a humanized, anti-carcinoembryonic antigen (hMN-14) antibody fragment.
    Leung SO, Karacay H, Losman MJ, Griffiths GL, Goldenberg DM, Hansen HJ.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5968s-5972s. PubMed ID: 7493378
    [Abstract] [Full Text] [Related]

  • 12. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
    Ma Q, DeMarte L, Wang Y, Stanners CP, Junghans RP.
    Cancer Gene Ther; 2004 Apr 01; 11(4):297-306. PubMed ID: 15002034
    [Abstract] [Full Text] [Related]

  • 13. Development of humanized antibodies as cancer therapeutics.
    Qu Z, Griffiths GL, Wegener WA, Chang CH, Govindan SV, Horak ID, Hansen HJ, Goldenberg DM.
    Methods; 2005 May 01; 36(1):84-95. PubMed ID: 15848077
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.
    Florent JC, Dong X, Gaudel G, Mitaku S, Monneret C, Gesson JP, Jacquesy JC, Mondon M, Renoux B, Andrianomenjanahary S, Michel S, Koch M, Tillequin F, Gerken M, Czech J, Straub R, Bosslet K.
    J Med Chem; 1998 Sep 10; 41(19):3572-81. PubMed ID: 9733483
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X, Clarke P, Szalai G, Shively JE, Williams LE, Shyr Y, Shi E, Primus FJ.
    Cancer Res; 2000 Aug 15; 60(16):4475-84. PubMed ID: 10969795
    [Abstract] [Full Text] [Related]

  • 20. The chimeric mouse-human anti-CD4 Fab 13B8.2 expressed in baculovirus inhibits both antigen presentation and HIV-1 promoter activation.
    Bès C, Cerutti M, Briant-Longuet L, Bresson D, Peraldi-Roux S, Pugnière M, Mani JC, Pau B, Devaux C, Granier C, Devauchelle G, Chardès T.
    Hum Antibodies; 2001 Aug 15; 10(2):67-76. PubMed ID: 11673661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.